NASDAQ

Repligen CORP

RGEN

3 stories

$10B Market cap · 2026-10-15

@BrokenMoats

Broken Moats on X

Someone really should investigate the price action into some of these ancillary biotech stocks.....very reminiscent of a certain Situational Awareness with chip stocks earlier in the year. No one is filing ownership and yet these stocks push higher regardless of macro, or geopolitical news or the overall index moves. Someone with swaps? or options likely at play then using the momentum pf retail and algos to add to the bid. The trade is melting up perfectly to the end of the quarter (not surprised to see them even more aggressively up today than usual to mark performance). We saw this with the chips trade after an unprecedented April-June. But some of the moves with this trade exceed that euphoria (Look at $TXG, $TWST, $SDGR, $RGEN, $GRAL, and a host of other companies)........DO we see the similar move after a giant quarter with a reversal to kick of the next quarter, that was the fate with chips and caused the fund to blow up. Be interesting to see if they learned any lessons, Im guessing not based on recent performance, and if it is a different player the strategy looks the same. These companies need financing and should hit the market bid which is what set off Viacom and was the undoing of Bill Huang in 2021. Lets see, but a basket of these stocks looks interesting at current levels sometime today for gravity/secondaries to come early in Q4
@BrokenMoats

Broken Moats on X

$DHR move this week is odd. I know its trading off $TMO today but the bioprocessing is the bigger piece to DHR and those sales/guide were disappointing and you saw weak action from https://t.co/sj9MDhumCh today off their numbers and even $RGEN trading off. $165 - $190 in two days this week seems off. Maybe the initial flush was over done, but hard to argue this business deserves to trade back at 200 where it came into earnings after seeing the bioprocessing commentary. Seems like a fade at 190
@BrokenMoats

Broken Moats on X

Sector action is bizarre today --- travel/discretionary (ex amazon (who posted very lousy prime sales) are surging), housing and adjacent like furniture ($w $wsm), biotech adjacent bid ($rgen, $medp) and waste stocks ($wcn). You want to derrick micron, I get it. And I get gas prices lower, market expects to fade out rate cuts that were priced moving forward as Warsh moves to trim mean/new data versus actually being hawkish, and some impact on a name like $hd off the housing bill. But all of these things are at the margin and known leading up to today --- so why target, kbh (on relatively inline to disappointing numbers yesterday) Expedia today versus yesterday? Market moves in very funny ways recently

Tickers on this page

Companies the stories above are also about, besides RGEN.